The Mounting Evidence for Permissive Hypercreatinemia in Acute Heart Failure: Adding Sodium Glucose Cotransporter Inhibitors to the List

Kidney360. 2023 Oct 1;4(10):1347-1349. doi: 10.34067/KID.0000000000000266.
No abstract available

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.
  • Editorial
  • Comment

MeSH terms

  • Canagliflozin
  • Heart Failure* / drug therapy
  • Humans
  • Sodium-Glucose Transport Proteins

Substances

  • Canagliflozin
  • Sodium-Glucose Transport Proteins